Abstract:Many studies have indicated that the expression of interleukin-21 (IL-21) is associated with the pathogenesis of certain liver diseases. However, in alternative animal models of liver diseases, it remains unknown whether the tree shrew could be utilized to analyze the relationship between IL-21 and liver diseases. Here, the phylogenetic tree, sequence alignment and protein structure model of tree shrew and human IL-21 were analyzed using bioinformatics software. A pEGFP-N3/tsIL-21 eukaryotic expression vector of tree shrew IL-21 (tsIL-21) was constructed, and IL-21 expression by the vector-transfected Huh7 cells was evaluated using the newly established quantitative real-time PCR and immunologic protocols for assessing human IL-21. The cytokine profiles were also evaluated in tree shrew spleen lymphocytes induced by recombinant human IL-21 or concanavalin A. It was found that the coding sequence (CDS) of tsIL-21 amplified from spleen lymphocytes belonged to the predicted sequence. The tsIL-21 was closely clustered with primate IL-21 rather than rodent IL-21, and it had an alignment of 83.33% with the human IL-21 nucleotide sequence and 69.93% with the amino acid sequence. The profiles of secondary structure, hydrophobicity and surface charge of tsIL-21 were also similar with those of human IL-21. The tsIL-21 expressed by the vector-transfected Huh7 cells could be identified by their different sources of antibodies against human IL-21, which were all dose-dependent. Recombinant human IL-21 could induce the change of the cytokine profiles of tree shrew spleen lymphocytes, which showed a higher expression of IL-10 and IFN-γ rather than IL-2, IL-4, IL-17, TNF-a and IL-21 during the five-day stimulation. These results indicate that tsIL-21 has a high degree of homology, structural similarity and immunological cross-reactivity with human IL-21 and also confirm the accuracy of this predicted tsIL-21CDS. The protocols utilized in this study will lead to the experimental feasibility of further IL-21-related studies in vivo.

Molecular cloning, expression and biological activity of rhesus macaque interleukin-17A and interleukin-17F

Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities

Assessment of Sequence Homology and Immunologic Cross-Reactivity Between Tree Shrew (tupaia Belangeri) and Human IL-21.

Preparation of Recombinant Human IL-17A and IL-17F and Determination of Their Bioactivities

Molecular characteristics of rhesus macaque interferon-lambda receptor 1 (mmuIFNLR1): Sequence identity, distribution and alteration after simian-human immunodeficiency virus infection in the skin and buccal mucosa

Preparation of a novel monoclonal antibody against caprine interleukin-17A and its applications in immunofluorescence and immunohistochemistry assays

Eukaryotic expression of the human interleukin 17F(hIL-17F) and its inducing effect on inflamation

Quantitative Analysis of CCL25,CCR9,CCL20 and CCR6 Transcription Levels in Gut-Associated Lymphoid Tissues of Rhesus Macaque

Cloning, expression and biological activity analysis of recombinant IL-17A in goat

Establishment of IL-17A/F BAC construct for transgenic reporter mice

IL-17F/IL-17R interaction stimulates granulopoiesis in mice.

Structural and Functional Insights into a Novel Pre-Clinical-stage Antibody Targeting IL-17A for Treatment of Autoimmune Diseases.

Molecular cloning, expression and characterization of the functional domain of CTLA4 from the rhesus monkey, Macaca mulatta.

[Prokaryotic Expression and Biological Activity of Recombinant Human IL-17F/His Protein].

Cloning and Prokaryotic Expression of IL-17 of Red Panda

Prokaryotic Expression of Mouse Interleukin 17A and Its Ability of Stimulating RAW264.7 Cell Inflammatory Factors Expression

[Eukaryotic Expression of Human IL17-RD-ECD and Generation of Its Monoclonal Antibody].

Prokaryotic Expression, Purification and Bioactivity of Recombinant Mouse Interleukin 17f/his Fusion Protein

IL-17A Functions and the Therapeutic Use of IL-17A and IL-17RA Targeted Antibodies for Cancer Treatment.

Identification and Functional Characterization of A Novel Interleukin 17 Receptor: A Possible Mitogenic Activation Through Ras/Mitogen-Activated Protein Kinase Signaling Pathway

IL-17/IL-17 Receptor System in Autoimmune Disease: Mechanisms and Therapeutic Potential